Global Hypoactive Sexual Desire Disorder Medication Industry Research & Trends Analysis Report
According to Market IntelliX Research, the global market for Hypoactive Sexual Desire Disorder Medication should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
China Hypoactive Sexual Desire Disorder Medication market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
The United States Hypoactive Sexual Desire Disorder Medication market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
In terms of type, Oral segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Hospital Pharmacy has a share approximately % in 2023 and will grow at a CAGR % during 2024 and 2030.
The global key manufacturers of Hypoactive Sexual Desire Disorder Medication include Sprout Pharmaceuticals, Inc., Covis Pharma GmbH, Mylan N.V., Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC., Zydus Group, Sun Pharmaceutical Industries Ltd, Abbvie,Inc and EndoCeutics, Inc., etc. In 2023, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Hypoactive Sexual Desire Disorder Medication. Report Highlights:
(1) Global Hypoactive Sexual Desire Disorder Medication market size (sales volume & revenue),history data from 2019-2024 and forecast data from 2024 to 2030.
(2) Global Hypoactive Sexual Desire Disorder Medication market competitive situation, sales, revenue, price and market share, from 2019 to 2024.
(3) China Hypoactive Sexual Desire Disorder Medication market competitive situation, sales, revenue, price and market share, from 2019 to 2024.
(4) Global Hypoactive Sexual Desire Disorder Medication segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Hypoactive Sexual Desire Disorder Medication segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Hypoactive Sexual Desire Disorder Medication, capacity, production and trends.
(7) Hypoactive Sexual Desire Disorder Medication industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Oral
Parenteral
Others
Market segment by application, can be divided into
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Market segment by players, this report covers
Sprout Pharmaceuticals, Inc.
Covis Pharma GmbH
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Amneal Pharmaceuticals LLC.
Zydus Group
Sun Pharmaceutical Industries Ltd
Abbvie,Inc
EndoCeutics, Inc.
S1 BIOPHARMA INC.
1 Market Overview
1.1 Hypoactive Sexual Desire Disorder Medication Definition
1.2 Global Hypoactive Sexual Desire Disorder Medication Market Size and Forecast
1.2.1 By Revenue, Global Hypoactive Sexual Desire Disorder Medication Market Size, 2019-2030
1.2.2 By Sales Volume, Global Hypoactive Sexual Desire Disorder Medication Market Size, 2019-2030
1.2.3 Global Hypoactive Sexual Desire Disorder Medication Price Trend, 2019-2030
1.3 China Hypoactive Sexual Desire Disorder Medication Market Size and Forecast
1.3.1 By Revenue, China Hypoactive Sexual Desire Disorder Medication Market Size, 2019-2030
1.3.2 By Sales Volume, China Hypoactive Sexual Desire Disorder Medication Market Size, 2019-2030
1.3.3 China Hypoactive Sexual Desire Disorder Medication Price Trend, 2019-2030
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Hypoactive Sexual Desire Disorder Medication Share in Global Market, 2019-2030
1.4.2 By Sales Volume, China Hypoactive Sexual Desire Disorder Medication Share in Global Market, 2019-2030
1.4.3 Hypoactive Sexual Desire Disorder Medication Market Size: China VS Global, 2019-2030
1.5 Hypoactive Sexual Desire Disorder Medication Market Dynamics
1.5.1 Hypoactive Sexual Desire Disorder Medication Market Drivers
1.5.2 Hypoactive Sexual Desire Disorder Medication Market Restraints
1.5.3 Hypoactive Sexual Desire Disorder Medication Industry Trends
1.5.4 Hypoactive Sexual Desire Disorder Medication Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Hypoactive Sexual Desire Disorder Medication Revenue by Company, 2019-2024
2.2 Global Hypoactive Sexual Desire Disorder Medication Sales Volume by Company, 2019-2024
2.3 Global Hypoactive Sexual Desire Disorder Medication Price by Company, 2019-2024
2.4 Global Hypoactive Sexual Desire Disorder Medication Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Hypoactive Sexual Desire Disorder Medication Concentration Ratio
2.6 Global Hypoactive Sexual Desire Disorder Medication Mergers & Acquisitions, Expansion Plans
2.7 Global Hypoactive Sexual Desire Disorder Medication Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Hypoactive Sexual Desire Disorder Medication Revenue by Company, 2019-2024
3.2 China Hypoactive Sexual Desire Disorder Medication Sales Volume by Company, 2019-2024
3.3 China Hypoactive Sexual Desire Disorder Medication Hypoactive Sexual Desire Disorder Medication Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Hypoactive Sexual Desire Disorder Medication Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)
3.5 Chinese Local Players, Hypoactive Sexual Desire Disorder Medication Domestic VS Export
3.6 China Market, Hypoactive Sexual Desire Disorder Medication Import & Export
3.6.1 China Market, Hypoactive Sexual Desire Disorder Medication Import & Export, 2019-2030
3.6.2 China Hypoactive Sexual Desire Disorder Medication Import & Export Trends
3.6.3 Main Sources of China Hypoactive Sexual Desire Disorder Medication Import
3.6.4 Export Destination of China Hypoactive Sexual Desire Disorder Medication
4 Hypoactive Sexual Desire Disorder Medication Production by Region
4.1 Global Hypoactive Sexual Desire Disorder Medication Capacity, Production and Capacity Utilization, 2019-2030
4.2 Global Geographic Distribution of Hypoactive Sexual Desire Disorder Medication Manufacturers
4.3 Global Major Manufacturers, Hypoactive Sexual Desire Disorder Medication Capacity Expansion and Future Plans
4.4 Global Hypoactive Sexual Desire Disorder Medication Capacity by Region
4.5 Global Hypoactive Sexual Desire Disorder Medication Production by Region
4.5.1 Global Hypoactive Sexual Desire Disorder Medication Production & Forecast by Region, 2019 VS 2024 VS 2030
4.5.2 Global Hypoactive Sexual Desire Disorder Medication Production by Region, 2019-2024
4.5.3 Global Hypoactive Sexual Desire Disorder Medication Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Hypoactive Sexual Desire Disorder Medication Industry Chain
5.2 Hypoactive Sexual Desire Disorder Medication Upstream Analysis
5.2.1 Hypoactive Sexual Desire Disorder Medication Core Raw Materials
5.2.2 Main Manufacturers of Hypoactive Sexual Desire Disorder Medication Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Hypoactive Sexual Desire Disorder Medication Production Mode
5.6 Hypoactive Sexual Desire Disorder Medication Procurement Model
5.7 Hypoactive Sexual Desire Disorder Medication Industry Sales Model and Sales Channels
5.7.1 Hypoactive Sexual Desire Disorder Medication Sales Model
5.7.2 Hypoactive Sexual Desire Disorder Medication Typical Distributors
6 Sights by Type
6.1 Hypoactive Sexual Desire Disorder Medication Classification
6.1.1 Oral
6.1.2 Parenteral
6.1.3 Others
6.2 By Type, Global Hypoactive Sexual Desire Disorder Medication Market Size & CAGR, 2019 VS 2024 VS 2030
6.3 By Type, Global Hypoactive Sexual Desire Disorder Medication Revenue, 2019-2030
6.4 By Type, Global Hypoactive Sexual Desire Disorder Medication Sales Volume, 2019-2030
6.5 By Type, Global Hypoactive Sexual Desire Disorder Medication Price, 2019-2030
7 Sights by Application
7.1 Hypoactive Sexual Desire Disorder Medication Segment by Application
7.1.1 Hospital Pharmacy
7.1.2 Online Pharmacy
7.1.3 Retail Pharmacy
7.2 By Application, Global Hypoactive Sexual Desire Disorder Medication Market Size & CAGR, 2019 VS 2024 VS 2030
7.3 By Application, Global Hypoactive Sexual Desire Disorder Medication Revenue, 2019-2030
7.4 By Application, Global Hypoactive Sexual Desire Disorder Medication Sales Volume, 2019-2030
7.5 By Application, Global Hypoactive Sexual Desire Disorder Medication Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Hypoactive Sexual Desire Disorder Medication Market Size, 2019 VS 2024 VS 2030
8.2 By Region, Global Hypoactive Sexual Desire Disorder Medication Revenue, 2019-2030
8.3 By Region, Global Hypoactive Sexual Desire Disorder Medication Sales Volume, 2019-2030
8.4 North America
8.4.1 North America Hypoactive Sexual Desire Disorder Medication Market Size & Forecasts, 2019-2030
8.4.2 By Country, North America Hypoactive Sexual Desire Disorder Medication Market Size Market Share
8.5 Europe
8.5.1 Europe Hypoactive Sexual Desire Disorder Medication Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Hypoactive Sexual Desire Disorder Medication Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Hypoactive Sexual Desire Disorder Medication Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Hypoactive Sexual Desire Disorder Medication Market Size Market Share
8.7 South America
8.7.1 South America Hypoactive Sexual Desire Disorder Medication Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Hypoactive Sexual Desire Disorder Medication Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Hypoactive Sexual Desire Disorder Medication Market Size & CAGR，2019 VS 2024 VS 2030
9.2 By Country, Global Hypoactive Sexual Desire Disorder Medication Revenue, 2019-2030
9.3 By Country, Global Hypoactive Sexual Desire Disorder Medication Sales Volume, 2019-2030
9.4 U.S.
9.4.1 U.S. Hypoactive Sexual Desire Disorder Medication Market Size, 2019-2030
9.4.2 By Company, U.S. Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2023
9.4.3 By Type, U.S. Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2023 VS 2030
9.4.4 By Application, U.S. Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2023 VS 2030
9.5 Europe
9.5.1 Europe Hypoactive Sexual Desire Disorder Medication Market Size, 2019-2030
9.5.2 By Company, Europe Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2023
9.5.3 By Type, Europe Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2023 VS 2030
9.5.4 By Application, Europe Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2023 VS 2030
9.6 China
9.6.1 China Hypoactive Sexual Desire Disorder Medication Market Size, 2019-2030
9.6.2 By Company, China Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2023
9.6.3 By Type, China Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2023 VS 2030
9.6.4 By Application, China Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2023 VS 2030
9.7 Japan
9.7.1 Japan Hypoactive Sexual Desire Disorder Medication Market Size, 2019-2030
9.7.2 By Company, Japan Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2023
9.7.3 By Type, Japan Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2023 VS 2030
9.7.4 By Application, Japan Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2023 VS 2030
9.8 South Korea
9.8.1 South Korea Hypoactive Sexual Desire Disorder Medication Market Size, 2019-2030
9.8.2 By Company, South Korea Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2023
9.8.3 By Type, South Korea Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2023 VS 2030
9.8.4 By Application, South Korea Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2023 VS 2030
9.9 Southeast Asia
9.9.1 Southeast Asia Hypoactive Sexual Desire Disorder Medication Market Size, 2019-2030
9.9.2 By Company, Southeast Asia Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2023
9.9.3 By Type, Southeast Asia Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2023 VS 2030
9.9.4 By Application, Southeast Asia Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2023 VS 2030
9.10 India
9.10.1 India Hypoactive Sexual Desire Disorder Medication Market Size, 2019-2030
9.10.2 By Company, India Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2023
9.10.3 By Type, India Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2023 VS 2030
9.10.4 By Application, India Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2023 VS 2030
9.11 Middle East & Asia
9.11.1 Middle East & Asia Hypoactive Sexual Desire Disorder Medication Market Size, 2019-2030
9.11.2 By Company, Middle East & Asia Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2023
9.11.3 By Type, Middle East & Asia Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2023 VS 2030
9.11.4 By Application, Middle East & Asia Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2023 VS 2030
10 Manufacturers Profile
10.1 Sprout Pharmaceuticals, Inc.
10.1.1 Sprout Pharmaceuticals, Inc. Company Information, Head Office, Market Area and Industry Position
10.1.2 Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
10.1.3 Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder Medication Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Sprout Pharmaceuticals, Inc. Company Profile and Main Business
10.1.5 Sprout Pharmaceuticals, Inc. Recent Developments
10.2 Covis Pharma GmbH
10.2.1 Covis Pharma GmbH Company Information, Head Office, Market Area and Industry Position
10.2.2 Covis Pharma GmbH Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
10.2.3 Covis Pharma GmbH Hypoactive Sexual Desire Disorder Medication Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.2.4 Covis Pharma GmbH Company Profile and Main Business
10.2.5 Covis Pharma GmbH Recent Developments
10.3 Mylan N.V.
10.3.1 Mylan N.V. Company Information, Head Office, Market Area and Industry Position
10.3.2 Mylan N.V. Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
10.3.3 Mylan N.V. Hypoactive Sexual Desire Disorder Medication Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Mylan N.V. Company Profile and Main Business
10.3.5 Mylan N.V. Recent Developments
10.4 Teva Pharmaceutical Industries Ltd.
10.4.1 Teva Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area and Industry Position
10.4.2 Teva Pharmaceutical Industries Ltd. Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
10.4.3 Teva Pharmaceutical Industries Ltd. Hypoactive Sexual Desire Disorder Medication Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Teva Pharmaceutical Industries Ltd. Company Profile and Main Business
10.4.5 Teva Pharmaceutical Industries Ltd. Recent Developments
10.5 Amneal Pharmaceuticals LLC.
10.5.1 Amneal Pharmaceuticals LLC. Company Information, Head Office, Market Area and Industry Position
10.5.2 Amneal Pharmaceuticals LLC. Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
10.5.3 Amneal Pharmaceuticals LLC. Hypoactive Sexual Desire Disorder Medication Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.5.4 Amneal Pharmaceuticals LLC. Company Profile and Main Business
10.5.5 Amneal Pharmaceuticals LLC. Recent Developments
10.6 Zydus Group
10.6.1 Zydus Group Company Information, Head Office, Market Area and Industry Position
10.6.2 Zydus Group Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
10.6.3 Zydus Group Hypoactive Sexual Desire Disorder Medication Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.6.4 Zydus Group Company Profile and Main Business
10.6.5 Zydus Group Recent Developments
10.7 Sun Pharmaceutical Industries Ltd
10.7.1 Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
10.7.2 Sun Pharmaceutical Industries Ltd Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
10.7.3 Sun Pharmaceutical Industries Ltd Hypoactive Sexual Desire Disorder Medication Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.7.4 Sun Pharmaceutical Industries Ltd Company Profile and Main Business
10.7.5 Sun Pharmaceutical Industries Ltd Recent Developments
10.8 Abbvie,Inc
10.8.1 Abbvie,Inc Company Information, Head Office, Market Area and Industry Position
10.8.2 Abbvie,Inc Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
10.8.3 Abbvie,Inc Hypoactive Sexual Desire Disorder Medication Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.8.4 Abbvie,Inc Company Profile and Main Business
10.8.5 Abbvie,Inc Recent Developments
10.9 EndoCeutics, Inc.
10.9.1 EndoCeutics, Inc. Company Information, Head Office, Market Area and Industry Position
10.9.2 EndoCeutics, Inc. Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
10.9.3 EndoCeutics, Inc. Hypoactive Sexual Desire Disorder Medication Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.9.4 EndoCeutics, Inc. Company Profile and Main Business
10.9.5 EndoCeutics, Inc. Recent Developments
10.10 S1 BIOPHARMA INC.
10.10.1 S1 BIOPHARMA INC. Company Information, Head Office, Market Area and Industry Position
10.10.2 S1 BIOPHARMA INC. Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
10.10.3 S1 BIOPHARMA INC. Hypoactive Sexual Desire Disorder Medication Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.10.4 S1 BIOPHARMA INC. Company Profile and Main Business
10.10.5 S1 BIOPHARMA INC. Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Hypoactive Sexual Desire Disorder Medication Market Size & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Hypoactive Sexual Desire Disorder Medication Market Restraints
Table 3. Hypoactive Sexual Desire Disorder Medication Market Trends
Table 4. Hypoactive Sexual Desire Disorder Medication Industry Policy
Table 5. Global Hypoactive Sexual Desire Disorder Medication Revenue by Company, 2019-2024, US$ million
Table 6. Global Hypoactive Sexual Desire Disorder Medication Revenue Market Share by Company, 2019-2024
Table 7. Global Hypoactive Sexual Desire Disorder Medication Sales Volume by Company, 2019-2024, (K Units)
Table 8. Global Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share by Company, 2019-2024
Table 9. Global Hypoactive Sexual Desire Disorder Medication Price by Company, 2019-2024, (US$/Unit)
Table 10. Global Hypoactive Sexual Desire Disorder Medication Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Hypoactive Sexual Desire Disorder Medication Mergers & Acquisitions, Expansion Plans
Table 12. Global Hypoactive Sexual Desire Disorder Medication Manufacturers Product Type
Table 13. China Hypoactive Sexual Desire Disorder Medication Revenue by Company, 2019-2024, US$ million
Table 14. China Hypoactive Sexual Desire Disorder Medication Revenue Market Share by Company, 2019-2024
Table 15. China Hypoactive Sexual Desire Disorder Medication Sales Volume by Company, 2019-2024, (K Units)
Table 16. China Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share by Company, 2019-2024
Table 17. China Market, Hypoactive Sexual Desire Disorder Medication Production, Sales, Import and Export, 2019-2030, (K Units)
Table 18. China Hypoactive Sexual Desire Disorder Medication Import & Export Trends
Table 19. Main Sources of China Hypoactive Sexual Desire Disorder Medication Import
Table 20. Export Destination of China Hypoactive Sexual Desire Disorder Medication
Table 21. Global Headquarters and Manufacturing Base of Hypoactive Sexual Desire Disorder Medication Manufacturers
Table 22. Global Major Manufacturers, Hypoactive Sexual Desire Disorder Medication Capacity Expansion and Future Plans
Table 23. Global Hypoactive Sexual Desire Disorder Medication Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)
Table 24. Global Hypoactive Sexual Desire Disorder Medication Production by Region, 2019-2024, (K Units)
Table 25. Global Hypoactive Sexual Desire Disorder Medication Production Forecast by Region, 2024-2030, (K Units)
Table 26. Global Key Players of Hypoactive Sexual Desire Disorder Medication Upstream (Raw Materials)
Table 27. Global Hypoactive Sexual Desire Disorder Medication Typical Customers
Table 28. Hypoactive Sexual Desire Disorder Medication Typical Distributors
Table 29. By Type, Global Hypoactive Sexual Desire Disorder Medication Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 30. By Application, Global Hypoactive Sexual Desire Disorder Medication Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 31. By Region, Global Hypoactive Sexual Desire Disorder Medication Market Size, 2019 VS 2024 VS 2030, US$ Million
Table 32. By Region, Global Hypoactive Sexual Desire Disorder Medication Revenue, 2019-2030, US$ Million
Table 33. By Region, Global Hypoactive Sexual Desire Disorder Medication Sales Volume, 2019-2030, (K Units)
Table 34. By Country, Global Hypoactive Sexual Desire Disorder Medication Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million
Table 35. By Country, Global Hypoactive Sexual Desire Disorder Medication Revenue, 2019-2030, US$ Million
Table 36. By Country, Global Hypoactive Sexual Desire Disorder Medication Revenue Market Share, 2019-2030
Table 37. By Country, Global Hypoactive Sexual Desire Disorder Medication Sales Volume, 2019-2030, (K Units)
Table 38. By Country, Global Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2019-2030
Table 39. Sprout Pharmaceuticals, Inc. Company Information, Head Office, Market Area and Industry Position
Table 40. Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
Table 41. Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 42. Sprout Pharmaceuticals, Inc. Company Profile and Main Business
Table 43. Sprout Pharmaceuticals, Inc. Recent Developments
Table 44. Covis Pharma GmbH Company Information, Head Office, Market Area and Industry Position
Table 45. Covis Pharma GmbH Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
Table 46. Covis Pharma GmbH Hypoactive Sexual Desire Disorder Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 47. Covis Pharma GmbH Company Profile and Main Business
Table 48. Covis Pharma GmbH Recent Developments
Table 49. Mylan N.V. Company Information, Head Office, Market Area and Industry Position
Table 50. Mylan N.V. Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
Table 51. Mylan N.V. Hypoactive Sexual Desire Disorder Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 52. Mylan N.V. Company Profile and Main Business
Table 53. Mylan N.V. Recent Developments
Table 54. Teva Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area and Industry Position
Table 55. Teva Pharmaceutical Industries Ltd. Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
Table 56. Teva Pharmaceutical Industries Ltd. Hypoactive Sexual Desire Disorder Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 57. Teva Pharmaceutical Industries Ltd. Company Profile and Main Business
Table 58. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 59. Amneal Pharmaceuticals LLC. Company Information, Head Office, Market Area and Industry Position
Table 60. Amneal Pharmaceuticals LLC. Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
Table 61. Amneal Pharmaceuticals LLC. Hypoactive Sexual Desire Disorder Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 62. Amneal Pharmaceuticals LLC. Company Profile and Main Business
Table 63. Amneal Pharmaceuticals LLC. Recent Developments
Table 64. Zydus Group Company Information, Head Office, Market Area and Industry Position
Table 65. Zydus Group Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
Table 66. Zydus Group Hypoactive Sexual Desire Disorder Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 67. Zydus Group Company Profile and Main Business
Table 68. Zydus Group Recent Developments
Table 69. Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
Table 70. Sun Pharmaceutical Industries Ltd Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
Table 71. Sun Pharmaceutical Industries Ltd Hypoactive Sexual Desire Disorder Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 72. Sun Pharmaceutical Industries Ltd Company Profile and Main Business
Table 73. Sun Pharmaceutical Industries Ltd Recent Developments
Table 74. Abbvie,Inc Company Information, Head Office, Market Area and Industry Position
Table 75. Abbvie,Inc Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
Table 76. Abbvie,Inc Hypoactive Sexual Desire Disorder Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 77. Abbvie,Inc Company Profile and Main Business
Table 78. Abbvie,Inc Recent Developments
Table 79. EndoCeutics, Inc. Company Information, Head Office, Market Area and Industry Position
Table 80. EndoCeutics, Inc. Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
Table 81. EndoCeutics, Inc. Hypoactive Sexual Desire Disorder Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 82. EndoCeutics, Inc. Company Profile and Main Business
Table 83. EndoCeutics, Inc. Recent Developments
Table 84. S1 BIOPHARMA INC. Company Information, Head Office, Market Area and Industry Position
Table 85. S1 BIOPHARMA INC. Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
Table 86. S1 BIOPHARMA INC. Hypoactive Sexual Desire Disorder Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 87. S1 BIOPHARMA INC. Company Profile and Main Business
Table 88. S1 BIOPHARMA INC. Recent Developments
List of Figure
Figure 1. Hypoactive Sexual Desire Disorder Medication Picture
Figure 2. By Revenue, Global Hypoactive Sexual Desire Disorder Medication Market Size and Forecast, 2019-2030, US$ Million
Figure 3. By Sales Volume, Global Hypoactive Sexual Desire Disorder Medication Market Size and Forecast, 2019-2030, (K Units)
Figure 4. Global Hypoactive Sexual Desire Disorder Medication Price Trend, 2019-2030, (US$/Unit)
Figure 5. By Revenue, China Hypoactive Sexual Desire Disorder Medication Market Size and Forecast, 2019-2030, US$ million
Figure 6. By Sales Volume, China Hypoactive Sexual Desire Disorder Medication Market Size and Forecast, 2019-2030, (K Units)
Figure 7. China Hypoactive Sexual Desire Disorder Medication Price Trend, 2019-2030 (US$/Unit)
Figure 8. By Revenue, China Hypoactive Sexual Desire Disorder Medication Share of Global Market, 2019-2030
Figure 9. By Sales Volume, China Hypoactive Sexual Desire Disorder Medication Share of Global Market, 2019-2030
Figure 10. Global Hypoactive Sexual Desire Disorder Medication Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Hypoactive Sexual Desire Disorder Medication Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Hypoactive Sexual Desire Disorder Medication Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Hypoactive Sexual Desire Disorder Medication Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Hypoactive Sexual Desire Disorder Medication Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024
Figure 15. Chinese Local Players, Proportion of Hypoactive Sexual Desire Disorder Medication Domestic VS Export, 2022
Figure 16. Global Hypoactive Sexual Desire Disorder Medication Capacity, Production and Capacity Utilization, 2019-2030
Figure 17. Global Hypoactive Sexual Desire Disorder Medication Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Hypoactive Sexual Desire Disorder Medication Production Market Share & Forecast by Region, 2019-2030
Figure 19. Hypoactive Sexual Desire Disorder Medication Industry Chain
Figure 20. Hypoactive Sexual Desire Disorder Medication Procurement Model
Figure 21. Hypoactive Sexual Desire Disorder Medication Sales Model
Figure 22. Hypoactive Sexual Desire Disorder Medication Sales Channels, Direct Sales and Distribution
Figure 23. Oral
Figure 24. Parenteral
Figure 25. Others
Figure 26. By Type, Global Hypoactive Sexual Desire Disorder Medication Revenue, 2019-2030, US$ Million
Figure 27. By Type, Global Hypoactive Sexual Desire Disorder Medication Revenue Market Share, 2019-2030
Figure 28. By Type, Global Hypoactive Sexual Desire Disorder Medication Sales Volume, 2019-2030, (K Units)
Figure 29. By Type, Global Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2019-2030
Figure 30. By Type, Global Hypoactive Sexual Desire Disorder Medication Price, 2019-2030, (US$/Unit)
Figure 31. Hospital Pharmacy
Figure 32. Online Pharmacy
Figure 33. Retail Pharmacy
Figure 34. By Application, Global Hypoactive Sexual Desire Disorder Medication Revenue, 2019-2030, US$ Million
Figure 35. By Application, Global Hypoactive Sexual Desire Disorder Medication Revenue Market Share, 2019-2030
Figure 36. By Application, Global Hypoactive Sexual Desire Disorder Medication Sales Volume, 2019-2030, (K Units)
Figure 37. By Application, Global Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2019-2030
Figure 38. By Application, Global Hypoactive Sexual Desire Disorder Medication Price, 2019-2030, (US$/Unit)
Figure 39. By Region, Global Hypoactive Sexual Desire Disorder Medication Revenue Market Share, 2019-2030
Figure 40. By Region, Global Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2019-2030
Figure 41. North America Hypoactive Sexual Desire Disorder Medication Revenue & Forecasts, 2019-2030, US$ Million
Figure 42. By Country, North America Hypoactive Sexual Desire Disorder Medication Revenue Market Share, 2022
Figure 43. Europe Hypoactive Sexual Desire Disorder Medication Revenue & Forecasts, 2019-2030, US$ Million
Figure 44. By Country, Europe Hypoactive Sexual Desire Disorder Medication Revenue Market Share, 2022
Figure 45. Asia Pacific Hypoactive Sexual Desire Disorder Medication Revenue & Forecasts, 2019-2030, US$ Million
Figure 46. By Country/Region, Asia Pacific Hypoactive Sexual Desire Disorder Medication Revenue Market Share, 2022
Figure 47. South America Hypoactive Sexual Desire Disorder Medication Revenue & Forecasts, 2019-2030, US$ Million
Figure 48. By Country, South America Hypoactive Sexual Desire Disorder Medication Revenue Market Share, 2022
Figure 49. Middle East & Africa Hypoactive Sexual Desire Disorder Medication Revenue & Forecasts, 2019-2030, US$ Million
Figure 50. U.S. Hypoactive Sexual Desire Disorder Medication Sales Volume, 2019-2030, (K Units)
Figure 51. By Company, U.S. Hypoactive Sexual Desire Disorder Medication Market Share, 2022
Figure 52. By Type, U.S. Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2022 VS 2029
Figure 53. By Application, U.S. Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2022 VS 2029
Figure 54. Europe Hypoactive Sexual Desire Disorder Medication Sales Volume, 2019-2030, (K Units)
Figure 55. By Company, Europe Hypoactive Sexual Desire Disorder Medication Market Share, 2022
Figure 56. By Type, Europe Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2022 VS 2029
Figure 57. By Application, Europe Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2022 VS 2029
Figure 58. China Hypoactive Sexual Desire Disorder Medication Sales Volume, 2019-2030, (K Units)
Figure 59. By Company, China Hypoactive Sexual Desire Disorder Medication Market Share, 2022
Figure 60. By Type, China Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2022 VS 2029
Figure 61. By Application, China Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2022 VS 2029
Figure 62. Japan Hypoactive Sexual Desire Disorder Medication Sales Volume, 2019-2030, (K Units)
Figure 63. By Company, Japan Hypoactive Sexual Desire Disorder Medication Market Share, 2022
Figure 64. By Type, Japan Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2022 VS 2029
Figure 65. By Application, Japan Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2022 VS 2029
Figure 66. South Korea Hypoactive Sexual Desire Disorder Medication Sales Volume, 2019-2030, (K Units)
Figure 67. By Company, South Korea Hypoactive Sexual Desire Disorder Medication Market Share, 2022
Figure 68. By Type, South Korea Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2022 VS 2029
Figure 69. By Application, South Korea Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2022 VS 2029
Figure 70. Southeast Asia Hypoactive Sexual Desire Disorder Medication Sales Volume, 2019-2030, (K Units)
Figure 71. By Company, Southeast Asia Hypoactive Sexual Desire Disorder Medication Market Share, 2022
Figure 72. By Type, Southeast Asia Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2022 VS 2029
Figure 73. By Application, Southeast Asia Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2022 VS 2029
Figure 74. India Hypoactive Sexual Desire Disorder Medication Sales Volume, 2019-2030, (K Units)
Figure 75. By Company, India Hypoactive Sexual Desire Disorder Medication Market Share, 2022
Figure 76. By Type, India Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2022 VS 2029
Figure 77. By Application, India Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2022 VS 2029
Figure 78. Middle East & Asia Hypoactive Sexual Desire Disorder Medication Sales Volume, 2019-2030, (K Units)
Figure 79. By Company, Middle East & Asia Hypoactive Sexual Desire Disorder Medication Market Share, 2022
Figure 80. By Type, Middle East & Asia Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2022 VS 2029
Figure 81. By Application, Middle East & Asia Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2022 VS 2029
Figure 82. Research Methodology
Figure 83. Breakdown of Primary Interviews
Figure 84. Bottom-up Approaches
Figure 85. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|